Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.

Via a program of reviews and original research articles, the journal is focused on linking diagnostic and prognostic biomarkers to appropriate therapy, with an emphasis on the development of companion diagnostic/therapeutic products, along with the analysis of pharmacogenomic data for drug development and therapeutic decision making.  

As a hybrid journal, Molecular Diagnosis & Therapy does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘Learn about publishing Open Access with us’ link below.

Molecular Drugs & Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Journal information

Editor
  • Alison Fitches
Publishing model
Hybrid. Learn about publishing Open Access with us

Journal metrics

4.074 (2020)
Impact factor
3.845 (2020)
Five year impact factor
14 days
Submission to first decision
93 days
Submission to acceptance
79,787 (2020)
Downloads

Latest articles

This journal has 67 open access articles

Journal updates

  • Digital Features

    Molecular Diagnosis & Therapy is able to host a range of digital features, with a number of options available to authors.

    Digital Features
View all updates

About this journal

Electronic ISSN
1179-2000
Print ISSN
1177-1062
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Current Contents/ Life Sciences
  4. Dimensions
  5. EBSCO Academic Search
  6. EBSCO Discovery Service
  7. EBSCO STM Source
  8. EMBASE
  9. EMBiology
  10. Google Scholar
  11. Japanese Science and Technology Agency (JST)
  12. Journal Citation Reports/Science Edition
  13. Medline
  14. Meta
  15. Naver
  16. OCLC WorldCat Discovery Service
  17. Pathway Studio
  18. ProQuest Agricultural & Environmental Science Database
  19. ProQuest Biological Science Database
  20. ProQuest Biotechnology Research Abstracts
  21. ProQuest Central
  22. ProQuest Engineering
  23. ProQuest Environmental Science
  24. ProQuest Health & Medical Collection
  25. ProQuest Health Research Premium Collection
  26. ProQuest Materials Science and Engineering Database
  27. ProQuest Medical Database
  28. ProQuest Natural Science Collection
  29. ProQuest SciTech Premium Collection
  30. ProQuest Technology Collection
  31. ProQuest-ExLibris Primo
  32. ProQuest-ExLibris Summon
  33. Reaxys
  34. SCImago
  35. SCOPUS
  36. Science Citation Index Expanded (SciSearch)
  37. TD Net Discovery Service
  38. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG